Bioprocess– tag –
-
Scaling Animal-Free Proteins from Precision Fermentation Faces Challenges: Cost and Process Control Barriers from Lab to Market
MDPI Switzerland Overview Scaling animal-free proteins produced via precision fermentation from lab to industrial production faces significant challenges, including maintaining strain performance, high media costs, and precise bioprocess... -
Continuous Bioprocessing Delivers Significant Gains in Biopharmaceutical Manufacturing Efficiency and Cost Reduction, Driven by 500L Single-Use Perfusion Bioreactors
BioProcess International USA Overview Biopharmaceutical manufacturers are rapidly adopting continuous bioprocessing, integrating upstream cell culture and downstream operations to boost productivity, cut costs, and reduce facility footpr... -
Vibro® Membrane Filtration: Sani Membranes Revolutionizes Biopharmaceutical Downstream with Anti-Fouling Innovation
Sani Membranes Denmark Overview Sani Membranes has introduced Vibro® Membrane Filtration (VMF) technology, an innovative solution poised to transform downstream bioprocessing. By employing a unique vibrational anti-fouling mechanism, VMF... -
Japan Prioritizes Quality in ‘China Plus One’ CDMO Strategy with Over $4 Billion Investment by FUJIFILM Diosynth and Others
BioProcess International USA Overview A BioProcess International article analyzes the 'China Plus One' strategy and biomanufacturing capacity in the APAC region. FUJIFILM Diosynth Biotechnologies has committed over $4 billion to global e... -
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
Continuous Chromatography & ICH Q13 Overcome Downstream Purification Challenges Amplified by Upstream Intensification
Separation Science Global Overview According to Separation Science, upstream bioreactor intensification, including N-1 perfusion seeding and high-density fed-batch, is creating new challenges for downstream purification. Continuous purif... -
MDPI Study Achieves mAb Yield Maximization and Cost Reduction Through Dynamic Simulation and Optimization of Fed-Batch Bioreactors
MDPI Global Overview A research paper published in MDPI demonstrates the effectiveness of dynamic simulation and optimization methods for fed-batch bioreactors in monoclonal antibody (mAb) production. Addressing the need for higher yield... -
Global Pharma and Biotech Firms Intensify Investment in Biologics Contract Manufacturing Market, openPR.com Reports
openPR.com USA Overview Global pharmaceutical and biotechnology companies are significantly increasing their investments in the biologics contract manufacturing (CDMO) market, as reported by openPR.com. FUJIFILM Diosynth Biotechnologies ... -
ArXiv Paper Unveils ‘Agentic Self-Driving Lab’ with LLMs and Bayesian Optimization to Accelerate Antibody Bioprocess, Drastically Reducing Experimental Costs and Timelines
ArXiv (Preprint server) USA Overview A paper published on ArXiv proposes an innovative 'agentic self-driving lab' concept, combining large language models (LLMs) and Bayesian optimization. Aimed at accelerating scientific discovery, incl... -
Separation Science Details AI and Machine Learning’s Role in Real-Time Process Monitoring and Predictive Control for Downstream Bioprocessing
Separation Science USA Overview Separation Science elaborates on how AI and machine learning are enabling real-time process monitoring and predictive control in downstream bioprocessing, particularly in chromatography purification. The a...
